Softgel Capsule Market Summary
According to Market Research Future analysis, the Softgel Capsule Market Size was valued at USD 4.619 Billion in 2024 & the market is projected to grow from USD 4.882 Billion in 2025 to USD 8.499 Billion by 2035, registering a CAGR of 5.7% during the forecast period 2025–2035. Rising global focus on preventive healthcare and nutritional supplementation is significantly driving the softgel capsule market, as consumers increasingly prefer easy-to-consume, highly bioavailable dosage forms that enhance absorption efficiency and support long-term wellness and chronic disease management across diverse populations.
According to WHO, over 1.9 billion adults were overweight in 2022, increasing demand for nutraceuticals, while CDC reports 6 in 10 adults have chronic diseases, boosting supplement usage; this growing disease burden positively supports softgel adoption globally.
Key Market Trends & Highlights
The Softgel Capsule Market is experiencing robust growth driven by evolving consumer preferences and technological advancements.
- North America leads with 45%+ share, driven by high healthcare spending and chronic disease prevalence supporting supplement adoption.
- Europe market valued at USD 1.023 billion in 2024, accounting for nearly 30% share with strong healthcare awareness.
- Nutraceuticals dominate with 38% share, driven by preventive healthcare demand and increasing global chronic disease burden across populations.
- Online retail leads with 41% share, supported by e-commerce growth and increasing consumer preference for convenient supplement purchasing platforms.
Market Size & Forecast
| 2024 Market Size | 4.619 (USD Billion) |
| 2035 Market Size | 8.499 (USD Billion) |
| CAGR (2025 - 2035) | 5.7% |
Major Players
Companies such as Catalent (US), Amway (US), BASF (DE), FMC Corporation (US), Lonza (CH), Soft Gel Technologies (US), Ginkgo BioWorks (US), Natural Alternatives International (US), Aenova Group (DE), EuroCaps (GB) are some of the major participants in the global market.